Works matching IS 09024441 AND DT 2021 AND VI 107 AND IP 3

Results: 12

TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 364, doi. 10.1111/ejh.13674

By:

Kuijvenhoven, Marianne A.;
Wilhelm, Abraham J.;
Meijer, Ellen;
Janssen, Jeroen J. W. M.;
Swart, Eleonora L.

Publication type:

Article

Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 354, doi. 10.1111/ejh.13673

By:

Novitzky‐Basso, Igor;
Chen, Carol;
Chen, Shiyi;
Lipton, Jeffrey H.;
Kim, Dennis D.;
Viswabandya, Auro;
Kumar, Rajat;
Lam, Wilson;
Law, Arjun;
Al‐Shaibani, Zeyad;
Gerbitz, Armin;
Pasic, Ivan;
Mattsson, Jonas;
Michelis, Fotios V.

Publication type:

Article

Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 343, doi. 10.1111/ejh.13672

By:

Ngai, Lok Lam;
Ma, Connie Y.;
Maguire, Orla;
Do, An D.;
Robert, Alberto;
Logan, Aaron C.;
Griffiths, Elizabeth A.;
Nemeth, Michael J.;
Green, Cherie;
Pourmohamad, Tony;
van Kuijk, Bo J.;
Snel, Alexander N.;
Kwidama, Zinia W.;
Venniker‐Punt, Bianca;
Cooper, James;
Manz, Markus G.;
Gjertsen, Bjørn T.;
Smit, Linda;
Ossenkoppele, Gert J.;
Janssen, Jeroen J. W. M.

Publication type:

Article

A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 333, doi. 10.1111/ejh.13671

By:

Monteith, Bethany E.;
Venner, Christopher P.;
Cheung, Matthew C.;
Pater, Joe;
Shepherd, Lois;
Richardson, Harriet;
Reece, Donna;
Gul, Engin;
Lalancette, Marc;
Castonguay, Vincent;
Kukreti, Vishal;
Tiedemann, Rodger;
Phua, Chai;
Bhella, Sita;
Dudebout, Jill;
Sherry, Max;
Yen, Hope;
Chen, Bingshu E.;
Hay, Annette E.

Publication type:

Article

Clinical and microbiological impact of long‐term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 377, doi. 10.1111/ejh.13670

By:

Verlinden, Anke;
Schroyens, Wilfried A.;
Gadisseur, Alain P.

Publication type:

Article

Radiation‐free myeloablative conditioning consisting of fludarabine added to full‐dose busulfan and cyclophosphamide in single‐unit cord blood transplantation for adults.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 374, doi. 10.1111/ejh.13669

By:

Konuma, Takaaki;
Monna‐Oiwa, Maki;
Isobe, Masamichi;
Okabe, Motohito;
Takahashi, Satoshi;
Tojo, Arinobu

Publication type:

Article

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 324, doi. 10.1111/ejh.13668

By:

Crysandt, Martina;
Soysal, Hatice;
Jennes, Eva;
Holtick, Udo;
Mrotzek, Matthias;
Rehnelt, Susanne;
Holderried, Tobias A. W.;
Wessiepe, Martina;
Kunter, Uta;
Wilop, Stefan;
Silling, Gerda;
Gecht, Judith;
Beier, Fabian;
Brümmendorf, Tim H.;
Jost, Edgar

Publication type:

Article

Baseline serum B‐cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 318, doi. 10.1111/ejh.13666

By:

Bujarski, Sean;
Goldwater, Marissa‐Skye;
Regidor, Bernard Sean;
Jew, Scott;
Daniely, David;
Swift, Regina A.;
Eades, Benjamin M.;
Emamy‐Sadr, Marsiye;
Souther, Eric;
Li, Mingjie;
Wang, Cathy;
Xu, Ning;
Chen, Haiming;
Spektor, Tanya M.;
Berenson, James R.

Publication type:

Article

Healthcare‐associated blood stream infections in hematological patients in Finland during the years 2006‐2016.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 311, doi. 10.1111/ejh.13663

By:

Åttman, Emilia;
Syrjänen, Jaana;
Lyytikäinen, Outi;
Ollgren, Jukka;
Sinisalo, Marjatta;
Vuento, Risto;
Mattila, Erja;
Huttunen, Reetta

Publication type:

Article

Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 301, doi. 10.1111/ejh.13649

By:

Shanmugasundaram, Krithika;
Goyal, Subir;
Switchenko, Jeffery;
Calzada, Oscar;
Churnetski, Michael C.;
Kolla, Bhaskar;
Bachanova, Veronika;
Gerson, James N.;
Barta, Stefan K.;
Gordon, Max J.;
Danilov, Alexey V.;
Grover, Natalie S.;
Mathews, Stephanie;
Burkart, Madelyn;
Karmali, Reem;
Sawalha, Yazeed;
Hill, Brian T.;
Ghosh, Nilanjan;
Park, Steven I.;
Epperla, Narendranath

Publication type:

Article

Issue Information.

Published in:: European Journal of Haematology, 2021, v. 107, n. 3, p. 299, doi. 10.1111/ejh.13449
Publication type:: Article

Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

Published in:

European Journal of Haematology, 2021, v. 107, n. 3, p. 370, doi. 10.1111/ejh.13667

By:

Renaud, Loïc;
Bossard, Jean Baptiste;
Carpentier, Benjamin;
Terriou, Louis;
Cambier, Nathalie;
Chanteau, Guillaume;
Escure, Guillaume;
Tilmont, Remi;
Barbieux, Sarah;
Wemeau, Mathieu;
Hieulle, Julia;
Boyle, Eileen M.;
Morschhauser, Franck

Publication type:

Article